HEIDI KILE: Open Payments
NPI 1245316470 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 16 payments from 8 companies in 2025. Trend: 2023 $468 · 2024 $278 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Amgen Inc. | 1 | $57 |
| Abbott Laboratories | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| Medtronic, Inc. | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
Products named: Wegovy, LEQVIO, JARDIANCE, CAMZYOS, AMPLATZER AMULET, COREVALVE EVOLUT R, CARDIOMEMS, FUROSCIX.
Industry payments across NE — which companies pay providers there.
